Improving Biopsy Experiences Study for Women
- Conditions
- Imaging Guided Breast Biopsy
- Interventions
- Behavioral: Supportive DialogueBehavioral: Guided MeditationBehavioral: Music
- Registration Number
- NCT01811043
- Lead Sponsor
- Duke University
- Brief Summary
The goal of this study is to examine whether a guided meditation intervention will reduce anxiety and distress as compared to a music intervention or radiologist supportive dialogue in women undergoing imaging-guided core needle breast biopsies. Both the guided meditation and music interventions are administered through use of headphones during routine outpatient imaging-guided core needle breast biopsies. Women in the guided meditation and music conditions will be given a CD with instructions for home practice. Women complete follow-up questionnaires in the 12 months after biopsy. Receipt of recommended follow-up care is examined for 60 months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 243
- 21 years old or older
- Undergoing imaging guided core needle biopsy
- Mammography or ultrasound Breast Imaging - Reporting and Data System(BI-RADS) final assessment category 3,4a-c, or 5
- Able to speak and read English
- Able to provide meaningful consent
- significant hearing impairment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Supportive Dialogue Supportive Dialogue Supportive dialogue is provided during biopsy by the radiologist performing the procedure Guided Meditation Guided Meditation Guided meditation is played via headphones during biopsy Music Music Music is played via headphones during biopsy
- Primary Outcome Measures
Name Time Method Change in Anxiety Change in anxiety from baseline (i.e., pre biopsy) assessment to post biopsy assessment will be examined. Participants will be followed for the duration of the biopsy, with an expected average of 1.5 hours between assessments. Anxiety is measured using the State Anxiety Scale of the State Trait Anxiety Inventory. Women complete this self-report measure at baseline (i.e., immediately prior to biopsy in the biopsy clinic) and immediately post-biopsy. Change in anxiety will be measured as change from baseline to post biopsy (i.e., post biopsy anxiety - baseline anxiety.) The expected duration from baseline to post biopsy assessment is expected to be an average of 1.5 hours.
- Secondary Outcome Measures
Name Time Method Rates of adherence to recommended follow-up care 60 months following biopsy Adherence to recommended mammography and clinical breast exam will be assessed for 60 months following biopsy. Adherence (i.e., repeated on schedule mammograms; repeated on schedule clinical breast exams) at 60 months post biopsy will be compared across study arms.
Trial Locations
- Locations (1)
Duke Cancer Institute
🇺🇸Durham, North Carolina, United States